MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

Atrium Therapeutics, Inc. (RNA)

Atrium Therapeutics, Inc. (RNA)

||
||
Financial Ratios
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Free Cash flow
-3,962
-33,241
-175,284
-156,885
Return on Equity
-9.517
-7.105
-13.994
-9.248
Net Profit Margin
-679.794
-84.711
-27,477.674
-1,398.405
Debt to Asset Ratio
23.506
19.926
13.761
11.618
Cash Ratio
229.573
1,222.776
195.715
206.122
Quick Ratio
872.956
1,303.652
920.186
1,157.304
Current Ratio
872.956
1,303.652
920.186
1,157.304

Time Plot

Show the time plot by selecting a row from the table.